# West Pharmaceutical Services

Type: Company (WST)

Source: GetYourBrief — https://getyourbrief.com/entity/west-pharmaceutical-services
Canonical HTML page: https://getyourbrief.com/entity/west-pharmaceutical-services

## Timeline

- **2026-09-01**: Public breach disclosure — Novocure publicly reported the cyberattack, disclosing that internal records of more than 1,400 U.S. patients were exposed.
- **2026-08-27**: Investigation remains unresolved — SecurityWeek reports no known cybercrime group has claimed responsibility; full scope, nature, and financial impact remain unknown.
- **2026-08-27**: No group claims responsibility — SecurityWeek reports no known cybercrime group has taken credit for the attack, and data breach status remains unclear.
- **2026-08-26**: Disclosure and market reaction — Company announces global operational disruption, including order processing and shipping systems; shares fall about 4% in morning trading. Evercore ISI estimates a 600-700 bps Q3 revenue impact if recovery mirrors Stryker's three-week timeline.
- **2026-08-26**: Public disclosure and stock decline — The company activates incident-response procedures, works with third-party cybersecurity specialists, and files an SEC statement. Shares fall roughly 4% in morning trading.
- **2026-08-25**: Cyber incident detected — Boston Scientific detects a cybersecurity incident affecting some IT systems.
- **2026-08-25**: Incident detected — Boston Scientific detects a cybersecurity incident affecting some IT systems, including those used to process and ship customer orders.
- **2026-08**: Unauthorized access occurs — Novocure says unauthorized access to certain information systems occurred in mid-August 2026, exposing internal patient records.
- **2026-08**: Incident response activated — Novocure activated its cybersecurity response plan, implemented containment measures, and initiated an internal investigation.

## Recent coverage (4 stories, network-wide)

### Novocure cyberattack exposes 1,400+ US patient records
2026-09-02 00:10:45 · Sector: health · Sentiment: Negative · Impact: 6/10 · Sources: 2

Novocure disclosed a mid-August cyberattack that exposed internal records of more than 1,400 U.S. oncology patients, along with provider contact details and employee job titles. The company said treatment devices were not accessed and that it expects no material financial impact. For healthcare IT and compliance leaders, the incident is another compelling case study in breach response, data classification, and regulatory risk.
Full story: https://gethealthbrief.com/story/novocure-cyberattack-1400-patient-records

### Boston Scientific Cyberattack Halts Order Shipments, Stock Drops 4%
2026-08-27 10:36:58 · Sector: cyber · Sentiment: Negative · Impact: 8/10 · Sources: 4

A cybersecurity incident at medical device maker Boston Scientific has disrupted global order processing and shipping systems. Security teams are watching for ransomware involvement and the scope of any data breach as recovery begins. The attack is the latest in a string of healthcare sector cyber incidents.
Full story: https://getcyberbrief.com/story/boston-scientific-cyberattack-order-shipments

### Boston Scientific Cyberattack Threatens Q3 Revenue by 600-700 bps
2026-08-27 10:33:48 · Sector: bio · Sentiment: Negative · Impact: 8/10 · Sources: 4

Boston Scientific's August 25 cyberattack has disrupted global order processing and shipping, creating clinical and financial uncertainty for the medical device maker. Evercore ISI estimates a 600-700 basis point hit to Q3 revenue if recovery follows Stryker's roughly three-week timeline. The company has not yet determined whether the incident will be material.
Full story: https://getbiobrief.com/story/boston-scientific-cyberattack-q3-revenue-bio

### Boston Scientific Cyberattack: Q3 Revenue Hit Could Top 600 bps
2026-08-27 00:34:29 · Sector: health · Sentiment: Negative · Impact: 8/10 · Sources: 3

A cybersecurity incident at Boston Scientific has disrupted order processing and shipping globally, threatening hospitals and surgical centers reliant on its devices. Analysts warn of a 600-700 bps Q3 revenue hit if recovery matches Stryker's three-week timeline. Health leaders must assess supply chain and patient care risks.
Full story: https://gethealthbrief.com/story/boston-scientific-cyberattack-health-impact

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getyourbrief.com/guides/methodology for the full editorial methodology.